Advair Hfa
Product manufactured by Glaxosmithkline Llc
Indications and Purposes
| 1 Indications And Usage Advair Hfa Is Indicated For The Twice-Daily Treatment Of Asthma In Patients Aged 12 Years And Older. Advair Hfa Should Be Used For Patients Not Adequately Controlled On A Long-Term Asthma Control Medication Such As An Inhaled Corticosteroid (Ics) Or Whose Disease Warrants Initiation Of Treatment With Both An Ics And Long-Acting Beta 2 -Adrenergic Agonist (Laba). Important Limitation Of Use Advair Hfa Is Not Indicated For The Relief Of Acute Bronchospasm. Advair Hfa Is A Combination Product Containing A Corticosteroid And A Long-Acting Beta 2 ‑adrenergic Agonist (Laba) Indicated For The Twice-Daily Treatment Of Asthma In Patients Aged 12 Years And Older. ( 1 ) Important Limitation Of Use: Not Indicated For Relief Of Acute Bronchospasm. ( 1 ) |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 2 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Fluticasone Propionate |
|
ZINC3920027 |
| 2. Salmeterol Xinafoate |
|
ZINC3785268 |